ALLERGY Net: High omalizumab dose controls recurrent reactions to venom immunotherapy in indolent systemic mastocytosis

Omalizumab-induced reductions in mast cell FcεRI expression and function

Lisa A. Beck, Gregory V. Marcotte, Donald MacGlashan et al. · Journal of Allergy and Clinical Immunology · 2004 · 445 citations

Inflammation, Omalizumab-induced Reductions, Signal Transduction +8

Omalizumab pretreatment decreases acute reactions after rush immunotherapy for ragweed-induced seasonal allergic rhinitis

Thomas B. Casale, William W. Busse, Joel N. Kline et al. · Journal of Allergy and Clinical Immunology · 2005 · 350 citations

Allergy, Allergy Medicine, Medicine +9

Omalizumab rapidly decreases nasal allergic response and FcεRI on basophils

Henry C. Lin, K.M. Boesel, D.T. Griffith et al. · Journal of Allergy and Clinical Immunology · 2004 · 266 citations · Full text

Elevated basal serum tryptase and hymenoptera venom allergy: relation to severity of sting reactions and to safety and efficacy of venom immunotherapy

Gabrielle Haeberli, Michael P. Brönnimann, T. Hunziker et al. · Clinical & Experimental Allergy · 2003 · 216 citations

Beekeepers anaphylaxis: successful immunotherapy covered by omalizumab

Johannes Schulze, Michael Rose, Stefan Zielen · Allergy · 2007 · 74 citations

Allergy, Allergy Medicine, Immunology +5